Navigation Links
Global Intranasal Drug Delivery Market 2014-2018: Key Vendors are Becton, Dickinson and Company, GlaxoSmithKline, Johnson & Johnson and Novartis
Date:8/26/2014

DUBLIN, Aug. 26, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Intranasal Drug Delivery Market 2014-2018" report to their offering.

Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. The nose is considered to be an ideal administrative route for needle-free vaccination and systematic drug delivery.

Continuous technological advancement is being made in intranasal drug delivery product to achieve efficient treatment facility. Intranasal drug delivery system plays a major role in improving the quality of the life of patients, by providing an easy mode of drug administration for patients on long-term therapy, as well as low risk of overdose and enhanced bioavailability.

The analysts forecast the Global Intranasal Drug Delivery market to grow at a CAGR of 2.92 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Intranasal Drug Delivery market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of the following intranasal drug delivery systems:

  • Nasal spray
  • Nasal drop
  • Nasal powder
  • Nasal gel
  • Nasal vaccine

The report, the Global Intranasal Drug Delivery market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Intranasal Drug Delivery market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

One of the emerging trends that the market is likely to experience is an increasing adoption of non-invasive administration products. As non-invasive nasal drug delivery increases the compliance of the patient through their convenient application, they find more preference among end-users.

According to the report, one of the major drivers in the market is the increasing aging population. With growing age, people are more susceptible to developing respiratory diseases. Hence, that is an important factor in increasing the demand for intranasal drug delivery products in the market.

Further, the report states that one of the major challenges in the market is a risk of overdosing, which causes various side-effects.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Introduction

06. Market Landscape

07. Market Segmentation by Product

08. Geographical Segmentation

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

17. Key Vendor Analysis

Companies Mentioned:

  • Becton
  • Dickinson and Company
  • GlaxoSmithKline
  • Johnson & Johnson
  • Novartis
  • Actiza Pharmaceutical
  • Aptar Group
  • Korten Pharmaceuticals
  • OptiNose
  • Patheon
  • Vee Remedies
  • Zymeth Wellness

For more information visit http://www.researchandmarkets.com/research/6nsnrd/global_intranasal

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net


'/>"/>
SOURCE Research and Markets
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Cytomegalovirus Retinitis Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Gilead Sciences, Hospira and Shire
2. Global Veterinary Diagnostics Market 2014-2018: Key Vendors are Abaxis, Heska, IDEXX Laboratories, Mindray Medical, VCA Antech and Zoetis
3. MNX Global Logistics renews multi-year contract with NuVasive, Inc.
4. Luminex Corporation To Present At Morgan Stanley Global Healthcare Conference
5. Depomed To Present At Morgan Stanley 2014 Global Healthcare Conference
6. Cardiomyopathy Global Clinical Trials Review, H2, 2014
7. Vascular Dementias Global Clinical Trials Review, H2, 2014
8. Vocal Cord Paralysis Global Clinical Trials Review, H2, 2014
9. Traumatic Pain Global Clinical Trials Review, H2, 2014
10. Traumatic Spinal Cord Injury Global Clinical Trials Review, H2, 2014
11. Tremor Global Clinical Trials Review, H2, 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE MKT: ... that developed an innovative way to use nonlinear optical ... delivery of new drugs. ... Dermatology Conference will show how researchers from BioPharmX and ... Medical School used a suite of imaging techniques in ...
(Date:10/11/2017)... 11, 2017  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), ... in Las Piedras, Puerto Rico , ... Following a ... sustained minor structural damage, temporary loss of power and ... been completed, manufacturing operations have resumed, and the company ...
(Date:10/7/2017)... 6, 2017   Provista, a proven leader ... billion in purchasing power, today announced a new resource ... The Newsroom is the online home for case ... expert bios, news releases, slideshows and events. ... wealth of resources at their fingertips, viewers can also ...
Breaking Medicine Technology:
(Date:10/13/2017)... Worth, TX (PRWEB) , ... October 13, 2017 ... ... financial planning agency serving communities in the greater Dallas, Miami, and Raleigh regions, ... young boy fighting to overcome a rare and deadly chromosome abnormality. , After ...
(Date:10/13/2017)... ... October 13, 2017 , ... The International Association of ... of excellence for the field of eating disorders, announces the opening of early ... in Orlando, Florida at the Omni Resort at ChampionsGate. , The ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers care ... have a waiver for care if the client has a cognitive impairment diagnosis. ... for care, is often waived, so the benefits from their insurance start immediately,” said ...
(Date:10/13/2017)... ... 13, 2017 , ... Talented host, actor Rob Lowe, is ... a new episode of "Success Files," which is an award-winning educational program broadcasted ... each subject in-depth with passion and integrity. , Sciatica occurs when the sciatic ...
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
Breaking Medicine News(10 mins):